BRII-B (02137) spent 1,786,000 Hong Kong dollars to repurchase 1.6 million shares on January 15th.
Tengsheng Pharmaceutical - B (02137) announced that the company invested 1.7886 million on January 15, 2025...
Announcement by BRII-B (02137), the company repurchased 1.6 million shares on January 15, 2025, at a cost of 1.7886 million Hong Kong dollars, with a repurchase price of 1.1-1.14 Hong Kong dollars per share.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
